Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Viridian Therapeutics (GB:0K1R)
LSE:0K1R
RESEARCH TOOLSreports
Holding GB:0K1R?
Track your performance easily
Viridian Therapeutics (0K1R) Ownership Overview
4.38% Insiders
21.58% Mutual Funds
60.26% Other Institutional Investors
10.74% ETFs
3.03% Public Companies and
Individual Investors
The ownership structure of Viridian Therapeutics (GB:0K1R) stock is a mix of institutional, retail, and individual investors. Approximately 92.59% of the company’s stock is owned by Institutional Investors, 4.38% is owned by Insiders, and 3.03% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Sep 30, 2024 | Stephen F. Mahoney President & Ceo,director | xxxxxxxxxxxxx | $499262 |
| Sep 17, 2024 | Fairmount Funds Management Llc Director, >10% Owner | xxxxxxxxxxxxx | $30000000 |
| Jan 24, 2024 | Fairmount Funds Management Llc Director, >10% Owner | xxxxxxxxxxxxx | $9999990 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2024 | xxxxxxxxxxxxx | $864 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $328350 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $11259521 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $18632136 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,702,837 | Institution | 4.67% | 66,884,345 | |
| 3,445,813 | Insider | 4.35% | 62,241,720 | |
| 3,445,813 | Institution | 4.35% | 62,241,720 | |
| 3,190,415 | Institution | 4.03% | 57,628,466 | |
| 2,812,665 | Institution | 3.55% | 50,805,168 | |
| 2,791,639 | Institution | 3.52% | 50,425,375 | |
| 2,505,738 | Institution | 3.16% | 45,261,145 | |
| 2,284,907 | Institution | 2.88% | 41,272,275 | |
| 2,203,641 | Institution | 2.78% | 39,804,367 | |
| 1,997,153 | Institution | 2.52% | 36,074,575 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,190,415 | Institution | 4.03% | 57,628,466 | |
| 2,505,738 | Institution | 3.16% | 45,261,145 | |
| 2,284,907 | Institution | 2.88% | 41,272,275 | |
| 2,203,641 | Institution | 2.78% | 39,804,367 | |
| 1,013,388 | Institution | 1.28% | 18,304,827 | |
| 899,710 | Institution | 1.14% | 16,251,462 | |
| 738,384 | Institution | 0.93% | 13,337,430 | |
| 705,216 | Institution | 0.89% | 12,738,317 | |
| 476,627 | Institution | 0.60% | 8,609,314 | |
| 313,029 | Institution | 0.40% | 5,654,243 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Viridian Therapeutics (GB:0K1R)?
According to the latest TipRanks data, approximately 60.26% of the company's stock is held by institutional investors, 4.38% is held by insiders, and 3.03% is held by retail investors.
What percentage of Viridian Therapeutics (GB:0K1R) stock is held by institutional investors?
According to the latest TipRanks data, approximately 60.26% of Viridian Therapeutics (GB:0K1R) stock is held by institutional investors.
What percentage of Viridian Therapeutics (GB:0K1R) stock is held by retail investors?
According to the latest TipRanks data, approximately 3.03% of Viridian Therapeutics (GB:0K1R) stock is held by retail investors.
Who owns the most shares of Viridian Therapeutics (GB:0K1R)?
Vanguard owns the most shares of Viridian Therapeutics (GB:0K1R).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.